Skip to main content

Want a detailed portfolio tracker?

Lifecore Biomedical (LFCR) Revenue (2010 - 2026)

Lifecore Biomedical (LFCR) revenue from Aug 29, 2010 to Mar 31, 2026. The TTM Lifecore Biomedical (LFCR) revenue is $6.98M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Lifecore Biomedical (LFCR) Revenue CAGR table

PeriodCAGR
1 Year TTM-94.64%
3 Years TTM-54.09%
5 Years TTM-43.95%
10 Years TTM-35.27%
All Time TTM-22.46%

Annual Revenue change of Lifecore Biomedical (LFCR)

YearRevenueChange
2026$23M+167.78%
2025$8.66M-93.25%
2024$128M+24.20%
2023$103MN/A
2022$0-100.00%
2021$26M+7.61%
2020$24M-83.32%
2019$143M+14.47%
2018$125M+1.71%
2017$122M+11.17%
2016$110MN/A
2015$0N/A
2014$0-100.00%
2013$442M+39.10%
2012$318M+14.75%
2011$277M+16.17%
2010$238MN/A

Comparison Lifecore Biomedical (LFCR) five years revenue CAGR with competitors

Lifecore Biomedical (LFCR) five years revenue CAGR is -46.06%.

TickerNamefive years Revenue CAGRUpside
SBFMSunshine Biopharma Inc295.66%-741.87%
UPCUniverse Pharmaceuticals Inc251.61%-646.26%
LQDALiquidia Corp137.36%-398.20%
INCRINC Research Holdings Inc95.06%-306.37%
BCRXBiocryst Pharmaceuticals Inc94.22%-304.56%
HIMSHims & Hers Health Inc - Class A69.18%-250.18%
XERSXeris Biopharma Holdings Inc62.01%-234.63%
ALVOAlvotech61.36%-233.21%
DVAXDynavax Technologies Corp54.48%-218.27%
CRONCronos Group Inc50.68%-210.03%
AVDLAvadel Pharmaceuticals plc49.45%-207.36%
ETONEton Pharmaceuticals Inc49.00%-206.38%
EOLSEvolus Inc38.94%-184.54%
HROWHarrow Inc38.62%-183.84%
INMInMed Pharmaceuticals Inc35.36%-176.77%
LNTHLantheus Holdings Inc35.28%-176.60%
ANIPANI Pharmaceuticals Inc34.07%-173.97%
OGIOrganiGram Holdings Inc28.29%-161.42%
NBIXNeurocrine Biosciences Inc24.30%-152.76%
HCMHUTCHMED (China) Ltd23.58%-151.19%
COLLCollegium Pharmaceutical Inc19.91%-143.23%
TLRYTilray Brands Inc19.06%-141.39%
UTHRUnited Therapeutics Corp16.05%-134.84%
RDYDr. Reddy`s Laboratories Ltd15.25%-133.11%
AMPHAmphastar Pharmaceuticals Inc14.37%-131.20%
PAHCPhibro Animal Health Corp - Class A13.43%-129.15%
ESPREsperion Therapeutics Inc12.35%-126.80%
IMCCIM Cannabis Corp12.18%-126.45%
SCYXScynexis Inc11.04%-123.97%
PCRXPacira BioSciences Inc10.65%-123.13%
AMRXAmneal Pharmaceuticals Inc - Class A8.92%-119.36%
ALKSAlkermes plc8.40%-118.23%
KMDAKamada Ltd7.79%-116.91%
EVOEvotec SE7.68%-116.67%
AYTUAytu BioPharma Inc7.34%-115.94%
SUPNSupernus Pharmaceuticals Inc6.90%-114.99%
ZTSZoetis Inc - Class A6.33%-113.74%
ORGOOrganogenesis Holdings Inc - Class A6.31%-113.69%
BHCBausch Health Companies Inc5.54%-112.03%
ELANElanco Animal Health Inc4.87%-110.58%
ACBAurora Cannabis Inc4.54%-109.87%
PBHPrestige Consumer Healthcare Inc2.91%-106.31%
VTRSViatris Inc2.82%-106.12%
PRGOPerrigo Company plc2.15%-104.66%
CPIXCumberland Pharmaceuticals Inc1.97%-104.27%
RMTIRockwell Medical Inc1.83%-103.97%
TEVATeva- Pharmaceutical Industries Ltd1.28%-102.77%
AQSTAquestive Therapeutics Inc0.84%-101.83%